Accession Number:

ADA413368

Title:

NMR with Combined Antiangiogenic and Radiation Therapies - Breast Cancer

Descriptive Note:

Final rept. 1 May 1999-30 Apr 2002

Corporate Author:

HENRY FORD HEALTH SYSTEM DETROIT MI

Personal Author(s):

Report Date:

2002-05-01

Pagination or Media Count:

18.0

Abstract:

New therapies that target tumor vasculature are receiving intense attention because they exhibit their effect preferentially on tumor vasculature compared with that of normal tissue. New therapies are combined with conventional treatment radiation therapy is a standard therapy for breast cancer. There are reasons to believe timing of drug and radiation would be important. The proposal is designed to investigate the effect of sequence and timing on tumor response following the combined adminiistration of drug and radiation. Furthermore, non-invasive tools for measuring blood flow and oxygen are used which have a potential direct clinical utility.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE